Urethritis
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
initial Gram stain suggestive of gonorrhea: nonpregnant
cephalosporin monotherapy or gentamicin plus azithromycin
For symptomatic people with initial Gram stain showing gram-negative intracellular diplococci, presumptive treatment for both gonococcal and nongonococcal urethritis should be given.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm [32]Unemo M, Ross Jdc, Serwin AB, et al. 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2020 Oct 29 [Epub ahead of print]. http://www.ncbi.nlm.nih.gov/pubmed/33121366?tool=bestpractice.com [42]Horner P, Blee K, O'Mahony C, et al; Clinical Effectiveness Group of the British Association for Sexual Health and HIV. 2015 UK national guideline on the management of non-gonococcal urethritis. Int J STD AIDS. 2016 Feb;27(2):85-96. http://www.bashh.org/documents/UK%20National%20Guideline%20on%20the%20Management%20of%20Non-gonococcal%20Urethritis%202015.pdf http://www.ncbi.nlm.nih.gov/pubmed/26002319?tool=bestpractice.com [43]British Association for Sexual Health and HIV. Urethritis and cervicitis. May 2023 [internet publication]. https://www.bashhguidelines.org/current-guidelines
The Centers for Disease Control and Prevention recommends a single dose of intramuscular ceftriaxone for uncomplicated gonorrhea.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
If ceftriaxone is not available, oral cefixime is a suitable alternative agent.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm Consult specialist for guidance on other alternative injectable cephalosporin options.
In patients who have a cephalosporin allergy, intramuscular gentamicin in a single dose plus a high dose of azithromycin may be considered; however, gastrointestinal adverse effects may limit the use of these regimens.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
Urethritis may facilitate HIV transmission. Treatment is the same in people with HIV as in people without HIV.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
All sex partners within the last 60 days should be referred for evaluation and possible treatment.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication].
https://www.cdc.gov/std/treatment-guidelines/default.htm
[44]Hogben M. Partner notification for sexually transmitted diseases. Clin Infect Dis. 2007 Apr 1;44(suppl 3):S160-74.
https://academic.oup.com/cid/article/44/Supplement_3/S160/496779
http://www.ncbi.nlm.nih.gov/pubmed/17342669?tool=bestpractice.com
[ ]
In people with sexually transmitted infections, what are the best strategies for partner notification?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.676/fullShow me the answer The management of a patient’s sex partners is an important consideration to prevent reinfection and further transmission.[47]Centers for Disease Control and Prevention. Sexually transmitted diseases: expedited partner therapy. April 2021 [internet publication].
https://www.cdc.gov/std/ept/default.htm
[Figure caption and citation for the preceding image starts]: Gram stain of urethral exudate showing gram-negative diplococci and polymorphonuclear leukocytesAdapted from Public Health Image Library, CDC; Jacobs N, 1974 [Citation ends].
Primary options
ceftriaxone: body weight <150 kg: 500 mg intramuscularly as a single dose; body weight ≥150 kg: 1000 mg intramuscularly as a single dose
Secondary options
cefixime: 800 mg orally as a single dose
Tertiary options
gentamicin: 240 mg intramuscularly as a single dose
and
azithromycin: 2 g orally as a single dose
doxycycline
Treatment recommended for SOME patients in selected patient group
If chlamydial infection has not been excluded, patients should also receive oral doxycycline for 7 days (unless they are receiving the gentamicin plus azithromycin regimen).[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
Primary options
doxycycline: 100 mg orally twice daily for 7 days
initial Gram stain suggestive of gonorrhea: pregnant
cephalosporin monotherapy
For symptomatic people with initial Gram stain showing gram-negative intracellular diplococci, presumptive treatment for both gonococcal and nongonococcal urethritis should be given.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm [32]Unemo M, Ross Jdc, Serwin AB, et al. 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2020 Oct 29 [Epub ahead of print]. http://www.ncbi.nlm.nih.gov/pubmed/33121366?tool=bestpractice.com [43]British Association for Sexual Health and HIV. Urethritis and cervicitis. May 2023 [internet publication]. https://www.bashhguidelines.org/current-guidelines
Pregnant women should be treated with ceftriaxone monotherapy first-line.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
Consultation with an infectious disease specialist is recommended if the patient has a cephalosporin allergy or there are any other considerations that preclude treatment with these agents.
Pregnant women should be retested to ensure cure, preferably with a nucleic acid amplification test such as ligase chain reaction or polymerase chain reaction of urethral discharge and/or urine sediment. Chlamydia test of cure is recommended 4 weeks after treatment, with a retest at 3 months. Retest for gonorrhea is recommended at 3 months.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
Urethritis may facilitate HIV transmission. Treatment is the same in people with HIV as in people without HIV.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
All sex partners within the last 60 days should be referred for evaluation and possible treatment.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication].
https://www.cdc.gov/std/treatment-guidelines/default.htm
[44]Hogben M. Partner notification for sexually transmitted diseases. Clin Infect Dis. 2007 Apr 1;44(suppl 3):S160-74.
https://academic.oup.com/cid/article/44/Supplement_3/S160/496779
http://www.ncbi.nlm.nih.gov/pubmed/17342669?tool=bestpractice.com
[ ]
In people with sexually transmitted infections, what are the best strategies for partner notification?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.676/fullShow me the answer The management of a patient’s sex partners is an important consideration to prevent reinfection and further transmission.[47]Centers for Disease Control and Prevention. Sexually transmitted diseases: expedited partner therapy. April 2021 [internet publication].
https://www.cdc.gov/std/ept/default.htm
[Figure caption and citation for the preceding image starts]: Gram stain of urethral exudate showing gram-negative diplococci and polymorphonuclear leukocytesAdapted from Public Health Image Library, CDC; Jacobs N, 1974 [Citation ends].
Primary options
ceftriaxone: 500 mg intramuscularly as a single dose
azithromycin
Treatment recommended for SOME patients in selected patient group
If chlamydial infection has not been excluded, a single dose of azithromycin is also recommended in pregnant women.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
Primary options
azithromycin: 1 g orally as a single dose
initial Gram stain not suggestive of gonorrhea: nonpregnant
doxycycline or azithromycin
Patients are initially treated for nongonococcal urethritis (NGU) alone with all symptomatic people having NAAT testing for Chlamydia trachomatis, Mycoplasma genitalium, and Neisseria gonorrhoea, even if initial Gram stain tests are negative for evidence of gonococci.[27]European Association of Urology. Guidelines on urological infections. 2023 [internet publication]. https://uroweb.org/guidelines/urological-infections
Presumptive treatment with doxycycline is recommended, as this drug is highly effective for C trachomatis and has some activity against M genitalium.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
Azithromycin should be considered as a secondary treatment option due to increasing reports of treatment failure and macrolide antimicrobial resistance with M genitalium.[29]Horner PJ, Blee K, Falk L, et al; International Union against Sexually Transmitted Infections. 2016 European guideline on the management of non-gonococcal urethritis. Int J STD AIDS. 2016 Oct;27(11):928-37. https://iusti.org/treatment-guidelines [48]Seña AC, Lensing S, Rompalo A, et al. Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy. J Infect Dis. 2012 Aug 1;206(3):357-65. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490700 http://www.ncbi.nlm.nih.gov/pubmed/22615318?tool=bestpractice.com A multi-day azithromycin dosing regimen may protect against inducingM genitalium resistance.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
Urethritis may facilitate HIV transmission. Treatment is the same in people with HIV as in people without HIV.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
All sex partners within the last 60 days should be referred for evaluation and possible treatment.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication].
https://www.cdc.gov/std/treatment-guidelines/default.htm
[44]Hogben M. Partner notification for sexually transmitted diseases. Clin Infect Dis. 2007 Apr 1;44(suppl 3):S160-74.
https://academic.oup.com/cid/article/44/Supplement_3/S160/496779
http://www.ncbi.nlm.nih.gov/pubmed/17342669?tool=bestpractice.com
[ ]
In people with sexually transmitted infections, what are the best strategies for partner notification?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.676/fullShow me the answer The management of a patient’s sex partners is an important consideration to prevent reinfection and further transmission.[47]Centers for Disease Control and Prevention. Sexually transmitted diseases: expedited partner therapy. April 2021 [internet publication].
https://www.cdc.gov/std/ept/default.htm
If subsequent nucleic acid amplification testing (NAAT) and/or culture testing results are available, the choice of antibiotic for definitive antibiotic therapy is based on the local epidemiology of specific infections and antimicrobial sensitivity patterns. If a NAAT is positive for gonorrhea, a culture should be performed before antigonococcal treatment is added.[29]Horner PJ, Blee K, Falk L, et al; International Union against Sexually Transmitted Infections. 2016 European guideline on the management of non-gonococcal urethritis. Int J STD AIDS. 2016 Oct;27(11):928-37. https://iusti.org/treatment-guidelines Consultation with an infectious disease specialist is recommended.
Primary options
doxycycline: 100 mg orally twice daily for 7 days
Secondary options
azithromycin: 1 g orally as a single dose; or 500 mg orally as a single dose, followed by 250 mg once daily for 4 days
initial Gram stain not suggestive of gonorrhea: pregnant
azithromycin or amoxicillin
Pregnant women should be treated with azithromycin first-line.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
Amoxicillin is an alternative treatment if chlamydial infection is detected.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
Doxycycline and flouroquinolones are not recommended in pregnancy.
Consultation with an infectious disease specialist is recommended if the patient has any considerations that preclude treatment with these regimens.
Pregnant women should be retested to ensure cure, preferably with a nucleic acid amplification test such as ligase chain reaction or polymerase chain reaction of urethral discharge and/or urine sediment. Chlamydia test of cure is recommended 4 weeks after treatment, with a retest at 3 months. Retest for gonorrhea is recommended at 3 months.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
Urethritis may facilitate HIV transmission. Treatment is the same in people with HIV as in people without HIV.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
All sex partners within the last 60 days should be referred for evaluation and possible treatment.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication].
https://www.cdc.gov/std/treatment-guidelines/default.htm
[44]Hogben M. Partner notification for sexually transmitted diseases. Clin Infect Dis. 2007 Apr 1;44(suppl 3):S160-74.
https://academic.oup.com/cid/article/44/Supplement_3/S160/496779
http://www.ncbi.nlm.nih.gov/pubmed/17342669?tool=bestpractice.com
[ ]
In people with sexually transmitted infections, what are the best strategies for partner notification?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.676/fullShow me the answer The management of a patient’s sex partners is an important consideration to prevent reinfection and further transmission.[47]Centers for Disease Control and Prevention. Sexually transmitted diseases: expedited partner therapy. April 2021 [internet publication].
https://www.cdc.gov/std/ept/default.htm
If subsequent nucleic acid amplification testing (NAAT) and/or culture testing results are available, the choice of antibiotic for definitive antibiotic therapy is based on the local epidemiology of specific infections and antimicrobial sensitivity patterns. If a NAAT is positive for gonorrhea, a culture should be performed before antigonococcal treatment is added.[29]Horner PJ, Blee K, Falk L, et al; International Union against Sexually Transmitted Infections. 2016 European guideline on the management of non-gonococcal urethritis. Int J STD AIDS. 2016 Oct;27(11):928-37. https://iusti.org/treatment-guidelines Consultation with an infectious disease specialist is recommended.
Primary options
azithromycin: 1 g orally as a single dose; or 500 mg orally as a single dose, followed by 250 mg once daily for 4 days
Secondary options
amoxicillin: 500 mg orally three times daily for 7 days
recurrent or resistant urethritis
repeat of initial treatment
If the patient did not complete initial treatment or was re-exposed by an untreated partner, he/she may be retreated with the same regimen as used initially.
alternative antibiotic therapy ± referral
Treatment failure should be considered in the following patients: patients whose symptoms do not resolve in 3-5 days after appropriate treatment and who report no sexual contact during the post-treatment period; patients with a positive test of cure (i.e., positive culture >72 hours or nucleic acid amplification test >7 days after receiving recommended treatment) and who report no sexual contact during the post-treatment period.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
In cases of suspected cephalosporin treatment failure, clinicians should obtain relevant clinical specimens for culture and consult an infectious disease specialist.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
For refractory cases, rare causes such as herpetic urethritis should be ruled out.
alternative antibiotic therapy ± referral
Treatment failure should be considered in the following patients: patients whose symptoms do not resolve in 3-5 days after appropriate treatment and who report no sexual contact during the post-treatment period; patients with a positive test of cure (i.e., positive culture >72 hours or nucleic acid amplification test >7 days after receiving recommended treatment) and who report no sexual contact during the post-treatment period.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
In areas where Trichomonas vaginalis is prevalent, men who have sex with women and have persistent or recurrent urethritis should be presumptively treated with metronidazole or tinidazole.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
If T vaginalis is unlikely, and Mycoplasma genitalium is detected on testing, resistance testing directs appropriate therapy.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm If M genitalium is macrolide resistant or resistance testing for M genitalium is unavailable, patients should be presumptively treated with doxycycline to decrease bacterial load, followed by moxifloxacin to clear the infection.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm Antibiotic regimens may vary according to local protocols; consult local guidance.
Systemic fluoroquinolone antibiotics, such as moxifloxacin, may cause serious, disabling, and potentially long-lasting or irreversible adverse events. This includes, but is not limited to, tendinopathy/tendon rupture; peripheral neuropathy; arthropathy/arthralgia; aortic aneurysm and dissection; heart valve regurgitation; dysglycemia; and central nervous system effects including seizures, depression, psychosis, and suicidal thoughts and behavior.[49]Rusu A, Munteanu AC, Arbănași EM, et al. Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile? Pharmaceutics. 2023 Mar 1;15(3). https://www.mdpi.com/1999-4923/15/3/804 http://www.ncbi.nlm.nih.gov/pubmed/36986665?tool=bestpractice.com Prescribing restrictions apply to the use of fluoroquinolones, and these restrictions may vary between countries. In general, fluoroquinolones should be restricted for use in serious, life-threatening bacterial infections only. Some regulatory agencies may also recommend that they must only be used in situations where other antibiotics, that are commonly recommended for the infection, are inappropriate (e.g., resistance, contraindications, treatment failure, unavailability). Consult your local guidelines and drug formulary for more information on suitability, contraindications, and precautions.
Patients with persistent or recurrent NGU after presumptive treatment for M genitalium or T vaginalis should be referred to a specialist for treatment.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
Treatment failures should prompt consultation with an infectious disease specialist and be reported to the Centers for Disease Control and Prevention through the local or state health department within 24 hours of diagnosis.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm
For refractory cases, rare causes such as herpetic urethritis should be ruled out.
All sex partners within the last 60 days should be referred for evaluation and possible treatment.[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication].
https://www.cdc.gov/std/treatment-guidelines/default.htm
[44]Hogben M. Partner notification for sexually transmitted diseases. Clin Infect Dis. 2007 Apr 1;44(suppl 3):S160-74.
https://academic.oup.com/cid/article/44/Supplement_3/S160/496779
http://www.ncbi.nlm.nih.gov/pubmed/17342669?tool=bestpractice.com
[ ]
In people with sexually transmitted infections, what are the best strategies for partner notification?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.676/fullShow me the answer The management of a patient’s sex partners is an important consideration to prevent reinfection and further transmission.[47]Centers for Disease Control and Prevention. Sexually transmitted diseases: expedited partner therapy. April 2021 [internet publication].
https://www.cdc.gov/std/ept/default.htm
Primary options
Trichomonas vaginalis
metronidazole: 2 g orally as a single dose
OR
Trichomonas vaginalis
tinidazole: 2 g orally as a single dose
OR
Mycoplasma genitalium, resistance testing available
doxycycline: 100 mg orally twice daily for 7 days
and
azithromycin: 1 g orally as a single dose, followed by 500 mg once daily for 3 days
OR
Mycoplasma genitalium, resistance testing unavailable or macrolide resistant
doxycycline: 100 mg orally twice daily for 7 days
and
moxifloxacin: 400 mg orally once daily for 7 days
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer